Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded over 30 years ago, 415 Capital is a venture capital firm based in Europe and North America, focusing on medical innovations. The firm manages investments ranging from €5-15 million and has a portfolio of over 10 companies. They have successfully exited notable companies such as Vesper Medical and Intact Vascular.
415 Capital invests in medical technologies at clinical through commercial stages, targeting sectors like structural heart disease, neurovascular disease, and medical robotics. Their check sizes range from €5-15 million, emphasizing innovations that improve patient outcomes in chronic diseases.
Notable portfolio companies include Endovascular Engineering, Laza Medical, and Supira Medical. Other investments feature R 3 Vascular, CorFlow Therapeutics, and Cardiac Success, among others.
Submit through their form at https://415capital.com/contact/.
415 Capital focuses exclusively on medical technologies that address significant unmet needs in chronic diseases, particularly in cardio and neurovascular conditions.
The firm invests in Series A, Series B, and Growth Equity stages, targeting companies that are at clinical through commercial stages.
Investment amounts typically range from €5-15 million per company, allowing for substantial support in the development of medical technologies.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.